A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Phase 1 Completed 116 enrolled Hoffmann-La Roche

RandomizedSequentialOpen-labelTreatment

This is a Phase 1 study to assess the safety and clinical activity of RO7623066 alone and in combination in patients with advanced solid tumors.

Evaluation	Drug	Modality	Dose	Route
Subject	RO7623066	Unknown	—	—
Background	Carboplatin	Small molecule	—	Intravenous
Background	Olaparib	Small molecule	—	Oral